Original from: Asia Business Outlook

Ant Group has announced a strategic partnership with Peking University Third Hospital in Beijing to establish a joint AI healthcare innovation laboratory.

The collaboration aims to develop advanced artificial intelligence applications in healthcare, marking Ant Group’s deeper entry into the rapidly expanding medical technology space. This partnership highlights the accelerating adoption of AI across China’s healthcare sector, projected to grow from $1.59 billion in 2023 to $16.02 billion by 2028, at a CAGR of 42.5 percent. By the end of 2025, nearly 90 percent of Chinese hospitals are expected to integrate AI solutions. Early successes, such as Tsinghua University’s AI hospital model, which achieved 93 percent diagnostic accuracy across 21 specialties, are fueling momentum and validating AI’s potential in clinical practice.

Key Highlights

· Ant Group partners with Peking University Hospital for AI healthcare

· China’s healthcare AI market set to grow 10x by 2028

· Alipay ecosystem gives Ant Group unique advantage in adoption

Unlike traditional tech companies entering healthcare, Ant Group benefits from its Alipay ecosystem, which already enables millions of users to access AI-driven symptom checkers, online consultations, and seamless healthcare transactions. This infrastructure gives Ant Group an edge in integrating new AI healthcare solutions directly into existing patient payment and service flows, creating a smoother adoption pathway.

Through its partnership with Peking University Third Hospital, Ant Group aims to co-develop clinical-grade AI applications, strengthening its role not only in digital payments but also in the delivery of next-generation healthcare solutions.

The collaboration reflects how tech-healthcare convergence is becoming essential for both institutions and patients as China positions itself at the forefront of global healthcare AI innovation.

Source: Ant Group, Peking University Partner On AI Healthcare Lab